BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 21052088)

  • 21. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
    McKelvie PA; Thompson PA; Tam CS
    Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.
    Siu LL; Wong KF; Chan JK; Kwong YL
    Am J Pathol; 1999 Nov; 155(5):1419-25. PubMed ID: 10550295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
    Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
    Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
    Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
    Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.
    Mori N; Yatabe Y; Oka K; Kinoshita T; Kobayashi T; Ono T; Asai J
    Am J Pathol; 1996 Aug; 149(2):699-705. PubMed ID: 8702007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia.
    Takata K; Hong ME; Sitthinamsuwan P; Loong F; Tan SY; Liau JY; Hsieh PP; Ng SB; Yang SF; Pongpruttipan T; Sukpanichnant S; Kwong YL; Hyeh Ko Y; Cho YT; Chng WJ; Matsushita T; Yoshino T; Chuang SS
    Am J Surg Pathol; 2015 Jan; 39(1):1-12. PubMed ID: 25188863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary bony peripheral T-cell lymphoma mimicking nasal type NK/T-cell lymphoma: a case report.
    Chuang SS; Lin CN; Li CY
    Pathol Res Pract; 2002; 198(5):369-73. PubMed ID: 12092774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.
    Ding W; Wang J; Zhao S; Yang Q; Sun H; Yan J; Gao L; Yao W; Zhang W; Liu W
    Pathol Res Pract; 2015 Jul; 211(7):544-9. PubMed ID: 25953340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New biomarkers in T-cell lymphomas.
    Bisig B; Gaulard P; de Leval L
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):13-28. PubMed ID: 22409820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
    Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.
    Fisch P; Meuer E; Pende D; Rothenfusser S; Viale O; Kock S; Ferrone S; Fradelizi D; Klein G; Moretta L; Rammensee HG; Boon T; Coulie P; van der Bruggen P
    Eur J Immunol; 1997 Dec; 27(12):3368-79. PubMed ID: 9464825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.
    Weidmann E; Hinz T; Klein S; Schui DK; Harder S; Kriener S; Kabelitz D; Hoelzer D; Mitrou PS
    Haematologica; 2000 Oct; 85(10):1024-31. PubMed ID: 11025592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
    Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
    Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1).
    Eberl M; Engel R; Aberle S; Fisch P; Jomaa H; Pircher H
    J Leukoc Biol; 2005 Jan; 77(1):67-70. PubMed ID: 15498816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
    Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
    J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the pathology, immunophenotype, etiology and genetic marker of NK/T-cell lymphoma].
    Zhong BN; Zhang XH; Li M; Cao HG; Li N; Liu CY; Gu YQ; Gao ZF
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):505-9. PubMed ID: 14690577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.